<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/257736-an-ophthalmic-solution by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 07:36:15 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 257736:AN OPHTHALMIC SOLUTION</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">AN OPHTHALMIC SOLUTION</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention discloses an ophthalmic solution comprising 0.001 to 10 weight percent of a simple saccharide, and at least 0.0001 weight percent of polyhexamethylene biguanide, and where the concentration of chloride in said solution is less than 0.2 percent by weight, wherein said ophthalmic solution is an aqueous solution effective as a single-part solution.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>AN OPHTHALMIC SOLUTION<br>
Field of the Invention<br>
The present invention relates to the field of ophthalmic solutions and their uses. In<br>
particular the invention relates to contact lens cleaning solutions, contact lens rinsing<br>
and storing solutions, solutions to deliver active pharmaceutical agents to the eye,<br>
solutions for disinfecting ophtalmic devices and the like.<br>
Background<br>
The present invention relates to the field of ophthalmic solutions and especially to<br>
the aspects of preservative efficacy and comfort after prolonged use. These<br>
ophthalmic solutions have been used for some period of time and are available as<br>
over the counter products. Solutions that are used in direct contact with corneal<br>
tissue such as the delivery of active pharmaceutical agent to the eye, or indirectly,<br>
such as the cleaning, conditioning or storage of devices that will come in contact with<br>
corneal tissue, such as contact lenses, there is a need to insure that these solution<br>
do not introduce sources of bacterial or other microbial infection. Thus<br>
preservatives are included to reduce the viability of microbes in the solution and to<br>
lessen the chance of contamination of the solution by the user since many of the<br>
solutions are bought, opened, used, sealed and then reused.<br>
State of the art preservative agents include polyhexamethylene biguanide (PHMB),<br>
Polyquad tm, chlorhexidine, and benzalkonium chloride, and the like, all of which at<br>
some concentration irritate corneal tissue and lead to user discomfort. Therefore, a<br>
solution that employs a given amount of a preservative agent, but which is made<br><br>
more effective by addition of an agent that is not a preservative agent would be<br>
desired.<br>
Summary of the Invention<br>
The present invention relates to improved ophthalmic solutions that employ inositol<br>
in order to more effectively preserve solutions and to reduce the degree to which<br>
cationic preservatives will deposit on contact lenses. Ophthalmic solutions are<br>
here understood to include contact lens treatment solutions, such as cleaners,<br>
soaking solutions, conditioning solutions and lens storage solutions, as well as<br>
wetting solutions and in-eye solutions for treatment of eye conditions.<br>
The solutions specifically described herein have 0.001 to about 1 percent of simple<br>
saccharides in combination with other active ingredients useful in ophthalmic<br>
solutions such as buffers, preservatives, surfactants, and antimicrobial agents, and<br>
with a low chloride concentration, less than about 0.2 percent by weight. It has been<br>
found, surprisingly that inositol, and other sugars including mannitol, sorbitol,<br>
sucrose, dextrose, glycerin and propylene glycol, effectively increase the<br>
antibacterial effect of preservatives in low salt (low chloride) conditions.<br>
The preservatives that are specifically useful are cationic polymeric preservatives<br>
such as polyhexamethylene biguanide (PHMB), Polyquad tm, chlorhexidne, and<br>
benzalkonium chloride, as well as other cationic preservatives that may prove useful<br>
in the present invention as well. The cationic preservatives are used at effective<br>
amounts as preservatives, and in the instance of PHMB from 0.0001,percent by<br>
weight to higher levels of about 0.01 weight percent. Specifcally, The cationic<br>
polymeric preservative includes polymeric biguanides such as polymeric<br>
hexamethylene biguanides (PHMB), and combinations thereof. Such cationic<br>
polymeric biguanides, and water-soluble salts thereof, having the following formula:<br><br><br>
wherein Z is an organic divalent bridging group which may be the same or different<br>
throughout the polymer, n is on average at least 3, preferably on average 5 to 20,<br>
and X1 and X2 are<br><br>
One preferred group of water-soluble polymeric biguanides will have number<br>
average molecular weights of at least 1,000 and more preferably will have number<br>
average molecular weights from 1,000 to 50,000. Suitable water-soluble salts of the<br>
free bases include, but are not limited to hydrochloride, borate, acetate, gluconate,<br>
sulfonate, tartrate and citrate salts.<br>
The above-disclosed biguanides and methods of preparation are described in the<br>
literature. For example, U.S. Pat. No. 3,428,576 describes the preparation of<br>
polymeric biguanides from a diamine and salts thereof and a diamine salt of<br>
dicyanimide.<br>
Most preferred are the polymeric hexamethylene biguanides, commercially available,<br>
for example, as the hydrochloride salt from Avecia (Wilmington, Del.) under the<br>
trademark Cosmocilâ„¢ CQ. Such polymers and water-soluble salts are referred to as<br>
polyhexamethylene (PHMB) or polyaminopropyl biguanide (PAPB). The term<br>
polyhexamethylene biguanide, as used herein, is meant to encompass one or more<br>
biguanides have the following formula:<br><br><br>
wherein Z, X1 and X2 are as defined above and n is from 1 to 500.<br>
Depending on the manner in which the biguanides are prepared, the predominant<br>
compound falling within the above formula may have different X1 and X2 groups or<br>
the same groups, with lesser amounts of other compounds within the formula. Such<br>
compounds are known and are disclosed in U.S. Pat. No. 4,758,595 and British<br>
Patent 1,432,345, which patents are hereby incorporated. Preferably, the water-<br>
soluble salts are compounds where n has an average value of 2 to 15, most<br>
preferably 3 to 12.<br>
It was found that an unexpected preservative efficacy was displayed when inositol<br>
was used in conjunction with the cationic preservative. The other components of<br>
the solution are used at levels known to those skilled in the art in order to improve<br>
the wearability of lenses and when used directly in the eye, to provide increased<br>
resistance to infection. Inositol used in ophthalmic solutions increases preservative<br>
efficacy in certain formulations, provides increased resistance to infection in corneal<br>
tissue, in certain formulations, and improves the quality of tears in certain<br>
formulations.<br>
The formulations may also include buffers such as phosphates, bicarbonate, citrate,<br>
borate, ACES, BES, BICINE, BIS-Tris, BlS-Tris Propane, HEPES, HEPPS,<br>
imidazole, Tris, MES, MOPS, PIPES, TAPS, TES, Glycine and Tricine<br>
Surfactants that might be employed include polysorbate surfactants, polyoxyethylene<br>
surfactants, phosphonates, saponins and polyethoxylated castor oils, but preerrably<br>
the polyethoxylated castor oils. These surfactants are commercially available. The<br>
polyethoxylated castor oils are sold by BASF under the trademark Cremaphor.<br><br>
Inositol, mannitol, sorbitol, sucrose, dextrose, glycerin, propylene glycol and the<br>
other agents used in the present invention are all commercially available, and well<br>
enough understood to be formulated into products within the scope of the invention<br>
by those skilled in the art.<br>
The solutions of the present invention may contain other additives including but not<br>
limited to buffers, tonicity agents, demulcents, wetting agents, preservatives,<br>
sequestering agents (chelating agents), surface active agents, and enzymes.<br>
Other aspects include adding to the solution from 0.001 to 1 weight percent chelating<br>
agent (preferably disodium EDTA) and/or additional microbicide, (preferably 0.00001<br>
to 0.1 or 0.0000 1 to 0.01) weight percent polyhexamethylene biquanide (PHMB, N-<br>
alkyl-2-pyrrolidone, chlorhexidine, polyquatemium-1, hexetidine, bronopol, alexidine,<br>
low concentrations of hydrogen peroxide, and ophthalmologically acceptable salts<br>
thereof<br>
Ophthalmologically acceptable chelating agents useful in the present invention<br>
include amino carboxylic acid compounds or water-soluble salts thereof, including<br>
ethylenediaminetetraacetic acid, nitrilotriacetic acid, diethylenetriamine pentaacetic<br>
acid, hydroxyethylethylenediaminetriacetic acid, 1,2-diaminocyclohexanetetraacetic<br>
acid, ethylene glycol bis (beta-aminoethyl ether) in N, N, N', N' tetraacetic acid<br>
(EGTA), aminodiacetic acid and hydroxyethylamino diacetic acid. These acids can<br>
be used in the form of their water soluble salts, particularly their alkali metal salts.<br>
Especially preferred chelating agents are the di-, tn- and tetra-sodium salts of<br>
ethylenediaminetetraacetic acid (EDTA), most preferably disodium EDTA (Disodium<br>
Edetate).<br>
Other chelating agents such as citrates and polyphosphates can also be used in the<br>
present invention. The citrates which can be used in the present invention include<br>
citric acid and its mono-, di-, and tri-alkaline metal salts. The polyphosphates which<br>
can be used include pyrophosphates, triphosphates, tetraphosphates,<br><br>
trimetaphosphates, tetrametaphosphates, as well as more highly condensed<br>
phosphates in the form of the neutral or acidic alkali metal salts such as the sodium<br>
and potassium salts as well as the ammonium salt.<br>
The pH of the solutions should be adjusted to be compatible with the eye and the<br>
contact lens, such as between 6.0 to 8.0, preferably between 6.8 to 7.8 or between<br>
7.0 to 7.6. Significant deviations from neutral (pH 7.3) will cause changes in the<br>
physical parameters (i.e. diameter) in some contact lenses. Low pH (pH less than<br>
5.5) can cause burning and stinging of the eyes, while very low or very high pH (less<br>
than 3.0 or greater than 10) can cause ocular damage.<br>
The additional preservatives employed in the present invention are known, such as<br>
polyhexamethylene biguanide, N-alkyl-2-pyrrolidone, chlorhexidine,<br>
polyhexamethylenebiguanide, alexidine, polyquatemium-1, hexetidine, bronopol and<br>
a very low concentration of hydrogen peroxide, e.g., 30 to 200 ppm.<br>
The solutions of the invention are compatible with both rigid gas permeable and<br>
hydrophilic contact lenses during storage, cleaning, wetting, soaking, rinsing and<br>
disinfection.<br>
A typical aqueous solution of the present invention may contain additional<br>
ingredients which would not affect the basic and novel characteristics of the active<br>
ingredients described earlier, such as tonicity agents, surfactants and viscosity<br>
inducing agents, which may aid in either the lens cleaning or in providing lubrication<br>
to the eye. Suitable tonicity agents include sodium chloride, potassium chloride,<br>
glycerol or mixtures thereof The tonicity of the solution is typically adjusted to<br>
approximately 240-310 milliosmoles per kilogram solution (mOsm/kg) to render the<br>
 solution compatible with ocular tissue and with hydrophilic contact lenses. In one<br>
embodiment, the solution contains 0.01 to 0.2 weight percent sodium chloride. The<br>
important factor is to keep the concentrations of such additives to a degree no<br>
greater than that would supply a chloride concentration of no greater than about 0.2<br><br>
mole percent.<br>
Suitable viscosity inducing agents can include lecithin or the cellulose derivatives<br>
such as hydroxymethylcellulose, hydroxypropylcellulose, hydroxypropyl-<br>
methylcellulose (HPMC), and methylcellulose in amounts similar to those for<br>
surfactants, above.<br>
Example 1<br>
An example of a formulation containing low salt, a buffer and cationic preservative<br>
follows:<br><br>
Column 1 shows the reduction of C. albicans at 2 hours using a typical antibacterial<br>
test. The data shows improved activity over the preservative alone; improved<br>
activity over the buffer control without sugar additive and improved activity over<br>
commercially available products<br><br><br><br>
This data shows that the antimicrobial activity of buffer with the sugar or glycol is<br>
greater than the preservative alone and that decreased acitivity at 0.5% sodium<br>
chloride or 0.5% potassium chloride solutions occurs as well. Thus the surprising<br>
effect of the sugar derived preservative enhancers is displayed and the effects<br>
relationship to chloride concentration is demonstrated.<br>
Example 3<br>
Solutions with a cationic polymeric preservative (PHMB) sodium chloride and<br>
glycerin and a buffer were made as shown in the following table and the preservative<br>
efficacy was measured.<br><br><br><br>
The above date illustrates the effect of sodium chloride on preservative efficacy and<br>
the effect of glycerin in improving preservative efficacy in low salt solutions.<br>
Example 4<br>
Solutions were made according to methods described supra with sodium phosphate<br>
as the buffer.<br><br>
This data illustrates the problem with sodium chloride is independent of buffer type.<br>
Example 5<br>
Solutions were formulated with sodium chloride, sorbitol and sucrose and then<br>
lenses were immersed in the resultant solutions and chlorohexidine gluconate was<br>
added. The lenses were exposed for 3 hours and the amount of the chlorohexidine<br>
deposited on the lens was measured.<br><br><br><br>
This test shows that the sugars used in the test have an ability to decrease the<br>
extent of preservative binding for of cationic preservatives when properly formulated.<br>
Both sorbitol and sucrose solutions demonstrated efficacy in reducing preservative<br>
deposition.<br>
Example 6<br>
The following experiment demonstrates the effect of chloride concentration on the<br>
antimicrobial effectiveness of PHMB preservative solutions.<br><br><br>
We claim:<br>
1.	An ophthalmic solution comprising 0.001 to 10 weight percent of a simple<br>
saccharide as a preservative enhancer chosen from the group consisting of:<br>
inositol; mannitol; sorbitol; sucrose; dextrose; ribose; triose; tetrose; erythrose;<br>
threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose;<br>
altrose; fructose; galactose; gulose; idose; mannose; sorbose; talose; tagatose;<br>
adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar<br>
alcohols; sorbitol; mannitol; xylitol; and polyol; and 0.0001 to 0.01 weight<br>
percent of polyhexamethylene biguanide, and where the concentration of<br>
chloride in said solution is less than or equal to 0.2 percent by weight.<br>
2.	An ophthalmic solution comprising 0.001 to 5 weight percent of a simple<br>
saccharide as a preservative enhancer chosen from the group consisting of:<br>
inositol; mannitol; sorbitol; sucrose; and dextrose; and 0.0001 to 0.01 weight<br>
percent of polyhexamethylene biguanide, and where the concentration of<br>
chloride in said solution is less than or equal to 0.2 percent by weight.<br>
3.	The ophthalmic solution of claim 1, wherein the concentration of<br>
polyhexamethylene biguanide is between 0.1 and 100 parts per million.<br>
4.	The ophthalmic solution of claim 1, optionally comprising a physiologically<br>
compatible buffer.<br>
5.	The ophthalmic solution of claim 4, wherein said physiologically compatible<br>
buffer is selected from the group consisting of: phosphate, bicarbonate, citrate,<br>
borate, ACES, acetate, BES, BICINE, BIS, BIS-Tris, BIS-Tris Propane,<br>
bicarbonate, histidine, HEPES, HEPPS, imidazole, MES, MOPS, PIPES,<br>
TAPS, TES, glycine, tiomethamine, and Tricine.<br>
6.	The ophthalmic solution of claim 1, optionally comprising a wetting agent.<br><br>
7.	The ophthalmic solution of claim 6 wherein said wetting agent is selected<br>
from the group consisting of: polysorbate surfactants, polyoxyethylene<br>
surfactants, polyethoxylated glycerides, phosphonates, saponins and<br>
polyethoxylated castor oils.<br>
8.	The ophthalmic solution of claim 1 optionally comprising a sequestering<br>
agent.<br>
9.	The ophthalmic solution of claim 8 wherein said sequestering agent is selected<br>
from the group consisting of: ethylenediaminetetraacetic acid, phosphonates,<br>
citrate, gluconate, nitrilotriacetic acid, diethylenetriamine pentaacetic acid,<br>
hydroxyethylethylenediaminetriacetic acid, 1,2-diaminocyclohexanetetraacetic<br>
acid, ethylene glycol bis (beta-aminoethyl ether), tetraacetic acid (EGTA),<br>
aminodiacetic acid, hydroxyethylamino diacetic acid, tartarate, and water-<br>
soluble salts thereof.<br><br><br><br>
ABSTRACT<br><br><br>
AN OPHTHALMIC SOLUTION<br>
The invention discloses an ophthalmic solution comprising 0.001 to 10 weight percent of a<br>
simple saccharide, and at least 0.0001 weight percent of polyhexamethylene biguanide, and<br>
where the concentration of chloride in said solution is less than 0.2 percent by weight, wherein<br>
said ophthalmic solution is an aqueous solution effective as a single-part solution.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtKDI0LTA5LTIwMTIpLUNPUlJFU1BPTkRFTkNFLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-(24-09-2012)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtKDI1LTA2LTIwMTMpLUNPUlJFU1BPTkRFTkNFLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-(25-06-2013)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtQVNTSUdOTUVOVC5wZGY=" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-ASSIGNMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtQ0FOQ0VMTEVEIFBBR0VTLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-CANCELLED PAGES.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtQ09SUkVTUE9OREVOQ0UucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtRVhBTUlOQVRJT04gUkVQT1JULnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtRk9STSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtRk9STSAxOC5wZGY=" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-FORM 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtRk9STSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtRk9STSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtRk9STSA2LnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-FORM 6.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1BBLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GPA.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1DTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1GT1JNIDEucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1GT1JNIDMucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1GT1JNIDUucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1TUEVDSUZJQ0FUSU9OLUNPTVBMRVRFLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-SPECIFICATION-COMPLETE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtR1JBTlRFRC1TUEVDSUZJQ0FUSU9OLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-GRANTED-SPECIFICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtSU5URVJOQVRJT05BTCBQVUJMSUNBVElPTi5wZGY=" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-INTERNATIONAL PUBLICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtSU5URVJOQVRJT05BTCBTRUFSQ0ggUkVQT1JUICYgT1RIRVJTLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-INTERNATIONAL SEARCH REPORT &amp; OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtT1RIRVJTLnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtUEVUSVRJT04gVU5ERVIgUlVMRSAxMzcucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtUFJJT1JJVFkgRE9DVU1FTlQucGRm" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-PRIORITY DOCUMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtUkVQTFkgVE8gRVhBTUlOQVRJT04gUkVQT1JULnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-REPLY TO EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NzM0LUtPTE5QLTIwMDMtVFJBTlNMQVRFRCBDT1BZIE9GIFBSSU9SSVRZIERPQ1VNRU5ULnBkZg==" target="_blank" style="word-wrap:break-word;">734-KOLNP-2003-TRANSLATED COPY OF PRIORITY DOCUMENT.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="257735-a-code-image-encoding-device.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="257737-single-processor-dual-motor-control.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>257736</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>734/KOLNP/2003</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>44/2013</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>01-Nov-2013</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>30-Oct-2013</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>06-Jun-2003</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>FXS VENTURES, LLC</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>22 FOX RUN LANE, SALEM, NEW HAMPSHIRE 03079, UNITED STATES OF AMERICA</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>SMITH FRANCIS XAVIER</td>
											<td>22 FOX RUN LANE, SALEM, NEW HAMPSHIRE 03079, U.S.A.</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 33/34</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/US2001/46344</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2001-11-08</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/246,870</td>
									<td>2000-11-08</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/257736-an-ophthalmic-solution by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 07:36:16 GMT -->
</html>
